Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2025
Switching the strict substrate specificities of the β-ketoacyl-acyl carrier protein synthases, FabH and BioZ
Xudong Hang, Lin Zhang, Yanqiang Huang, et al.
Diagnostic Microbiology and Infectious Disease
|
August 3, 2020
In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China
Yanmei Yang, Lijun Bian, Xudong Hang, et al.
Journal of Bacteriology
|
July 31, 2019
The Cyclopropane Fatty Acid Synthase Mediates Antibiotic Resistance and Gastric Colonization of Helicobacter pylori
Xueqing Jiang, Yuanyuan Duan, Boshen Zhou, et al.
Microbial Biotechnology
|
March 29, 2021
Armeniaspirol A: a novel anti-Helicobacter pylori agent
Jia Jia, Chongwen Zhang, Yaqi Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 16, 2025
Antagonist Targeting the Species-Specific Fatty Acid Dehydrogenase/Isomerase FabX for Anti-H. pylori Infection
Lin Zhang, Xiaoxue Ruan, Xudong Hang, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2024
Correction for Chen et al., "Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination"
Tianyu Chen, Jing Yao, Keao Quan, et al.
Virulence
|
June 2, 2026
Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against <i>Candida albicans</i>
Jing Yao, Zhiyu Yang, Xudong Hang, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Design, Synthesis, and Biological Evaluation of 5-(5-Iodo-2-isopropyl-4-methoxyphenoxy)pyrimidine-2,4-diamine (AF-353) Derivatives as Novel DHFR Inhibitors against <i>Staphylococcus aureus</i>
Zongkai Huang, Xupeng Gou, Xudong Hang, et al.
Antimicrobial Agents and Chemotherapy
|
November 29, 2023
Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination
Tianyu Chen, Jing Yao, Keao Quan, et al.
Antimicrobial Agents and Chemotherapy
|
April 24, 2024
Loureirin A is a narrow-spectrum antimicrobial agent against <i>Helicobacter pylori</i>
Qian Tong, Chengqiang Yin, Xudong Hang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2025
Switching the strict substrate specificities of the β-ketoacyl-acyl carrier protein synthases, FabH and BioZ
Xudong Hang, Lin Zhang, Yanqiang Huang, et al.
Diagnostic Microbiology and Infectious Disease
|
August 3, 2020
In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China
Yanmei Yang, Lijun Bian, Xudong Hang, et al.
Journal of Bacteriology
|
July 31, 2019
The Cyclopropane Fatty Acid Synthase Mediates Antibiotic Resistance and Gastric Colonization of Helicobacter pylori
Xueqing Jiang, Yuanyuan Duan, Boshen Zhou, et al.
Microbial Biotechnology
|
March 29, 2021
Armeniaspirol A: a novel anti-Helicobacter pylori agent
Jia Jia, Chongwen Zhang, Yaqi Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 16, 2025
Antagonist Targeting the Species-Specific Fatty Acid Dehydrogenase/Isomerase FabX for Anti-H. pylori Infection
Lin Zhang, Xiaoxue Ruan, Xudong Hang, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2024
Correction for Chen et al., "Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination"
Tianyu Chen, Jing Yao, Keao Quan, et al.
Virulence
|
June 2, 2026
Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against <i>Candida albicans</i>
Jing Yao, Zhiyu Yang, Xudong Hang, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Design, Synthesis, and Biological Evaluation of 5-(5-Iodo-2-isopropyl-4-methoxyphenoxy)pyrimidine-2,4-diamine (AF-353) Derivatives as Novel DHFR Inhibitors against <i>Staphylococcus aureus</i>
Zongkai Huang, Xupeng Gou, Xudong Hang, et al.
Antimicrobial Agents and Chemotherapy
|
November 29, 2023
Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination
Tianyu Chen, Jing Yao, Keao Quan, et al.
Antimicrobial Agents and Chemotherapy
|
April 24, 2024
Loureirin A is a narrow-spectrum antimicrobial agent against <i>Helicobacter pylori</i>
Qian Tong, Chengqiang Yin, Xudong Hang, et al.
Page
of 3